KCNV1 Gene

Migration, Crosslink

📖

KCNV1 Gene

active

wiki page Created: 2026-04-02T07:19:33 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-kcnv1

📖 Wiki Page

gene1572 wordssynced 2026-04-02

KCNV1 Gene — Potassium Voltage-Gated Channel Modifier Subfamily V Member 1

Overview

The KCNV1 gene (Potassium Voltage-Gated Channel Modifier Subfamily V Member 1) encodes a regulatory beta subunit of voltage-gated potassium (Kv) channels. While initially characterized for its role in modulating neuronal excitability, emerging research suggests potential implications for neurodegenerative diseases through its effects on neuronal potassium homeostasis, axonal conduction, and cellular stress responses. [@voltagegated2020]

| Property | Value |
|----------|-------|
| Gene Symbol | KCNV1 |
| Gene Name | Potassium Voltage-Gated Channel Modifier Subfamily V Member 1 |
| Chromosomal Location | 8p23.1 |
| NCBI Gene ID | [27040](https://www.ncbi.nlm.nih.gov/gene/27040) |
| OMIM | [609138](https://www.omim.org/entry/609138) |
| UniProt | [Q9NWV8](https://www.uniprot.org/uniprot/Q9NWV8) |
| Ensembl | [ENSG00000167614](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167614) |
| Protein Family | Kv channel beta subunit (KCNB) family |

</div>

Introduction

Voltage-gated potassium channels are essential for maintaining neuronal resting membrane potential, regulating action potential firing patterns, and controlling neurotransmitter release. The KCNV1 protein, also known as Kv channel subunit beta-1 (Kvbeta1) or simply Kv beta, functions as a regulatory subunit that modulates the trafficking, gating properties, and functional expression of voltage-gated potassium channel alpha subunits.

...

KCNV1 Gene — Potassium Voltage-Gated Channel Modifier Subfamily V Member 1

Overview

The KCNV1 gene (Potassium Voltage-Gated Channel Modifier Subfamily V Member 1) encodes a regulatory beta subunit of voltage-gated potassium (Kv) channels. While initially characterized for its role in modulating neuronal excitability, emerging research suggests potential implications for neurodegenerative diseases through its effects on neuronal potassium homeostasis, axonal conduction, and cellular stress responses. [@voltagegated2020]

| Property | Value |
|----------|-------|
| Gene Symbol | KCNV1 |
| Gene Name | Potassium Voltage-Gated Channel Modifier Subfamily V Member 1 |
| Chromosomal Location | 8p23.1 |
| NCBI Gene ID | [27040](https://www.ncbi.nlm.nih.gov/gene/27040) |
| OMIM | [609138](https://www.omim.org/entry/609138) |
| UniProt | [Q9NWV8](https://www.uniprot.org/uniprot/Q9NWV8) |
| Ensembl | [ENSG00000167614](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167614) |
| Protein Family | Kv channel beta subunit (KCNB) family |

</div>

Introduction

Voltage-gated potassium channels are essential for maintaining neuronal resting membrane potential, regulating action potential firing patterns, and controlling neurotransmitter release. The KCNV1 protein, also known as Kv channel subunit beta-1 (Kvbeta1) or simply Kv beta, functions as a regulatory subunit that modulates the trafficking, gating properties, and functional expression of voltage-gated potassium channel alpha subunits.

Unlike classical Kv channel alpha subunits that form the pore, KCNV1 belongs to the Kv channel modifier subfamily and exerts its effects by forming heteromultimeric complexes with other Kv channel subunits. This modulation is critical for fine-tuning neuronal electrical signaling in various brain regions.

Protein Structure and Function

Structural Features

KCNV1 encodes a protein of approximately 465 amino acids with a molecular weight of approximately 50 kDa. The protein contains several functional domains:

N-terminal Cytoplasmic Domain: Contains the primary structure responsible for interaction with Kv channel alpha subunits and modulation of channel trafficking.

Transmembrane Segment: A single transmembrane helix that anchors the protein in the neuronal membrane.

C-terminal Cytoplasmic Domain: Involved in protein-protein interactions and post-translational modifications.

The KCNV1 protein lacks the characteristic pore-forming regions of canonical Kv channel alpha subunits but contains a highly conserved Rossmann-fold-like structure in its cytoplasmic domain that facilitates interaction with the T1 tetramerization domain of Kv alpha subunits.

Channel Modulation

KCNV1 modulates potassium channel function through several mechanisms:

Trafficking Enhancement: KCNV1 promotes the forward trafficking of Kv1.x channel complexes from the endoplasmic reticulum to the plasma membrane, increasing surface expression of functional channels.

Gating Modification: When incorporated into channel complexes, KCNV1 can alter voltage-dependent activation and inactivation kinetics, often accelerating inactivation or shifting voltage dependence.

Formation of Heteromultimers: KCNV1 can co-assemble with various Kv channel alpha subunits (particularly Kv1.x family members) to form heteromeric channels with distinct biophysical properties.

Inactivation Modulation: The protein can confer or enhance N-type inactivation in channels that naturally lack this property, providing an additional layer of regulation.

Expression Pattern

KCNV1 exhibits a widespread but specific expression pattern in the central nervous system:

Brain Regions: High expression in [hippocampus](/brain-regions/hippocampus) (particularly CA1 pyramidal neurons), cerebral [cortex](/brain-regions/cortex), cerebellum (Purkinje cells), and various subcortical nuclei.
Cellular Localization: Primarily localized to neuronal soma and proximal dendrites, with some expression in axons.
Development: Expression levels increase during postnatal development, coinciding with neuronal maturation and synaptogenesis.

Role in Neuronal Physiology

Membrane Excitability

By modulating Kv channel function, KCNV1 plays a crucial role in regulating neuronal membrane excitability:

Resting Membrane Potential: Enhanced Kv channel activity due to KCNV1 contributes to maintaining appropriate resting membrane potential.

Action Potential Dynamics: Modified Kv channel kinetics influence action potential shape, duration, and firing frequency.

Repolarization: Accelerated repolarization due to enhanced K+ efflux prevents excessive depolarization and calcium entry.

Synaptic Transmission

KCNV1 modulates synaptic transmission through its effects on:

Presynaptic Terminals: Altered action potential waveform affects calcium influx and neurotransmitter release probability.

Postsynaptic Responses: Modified dendritic excitability influences synaptic integration and plasticity.

Network Oscillations: KCNV1 contributes to gamma oscillations and other rhythmic activities critical for cognitive function.

Axonal Conduction

The protein affects axonal physiology:

Action Potential Propagation: Appropriate Kv channel density ensures reliable action potential propagation.

Node of Ranvier Function: At presynaptic terminals and nodes, KCNV1 modulates excitability.

Axonal Initial Segment: Critical for action potential initiation.

Implications for Neurodegenerative Diseases

Alzheimer's Disease

While direct evidence linking KCNV1 to Alzheimer's disease pathogenesis is limited, several mechanisms suggest potential involvement:

Neuronal Hyperexcitability: Early in AD, network hyperexcitability is observed. KCNV1 modulation of Kv channels could contribute to this phenotype.

Calcium Dysregulation: Altered neuronal excitability leads to calcium dysregulation, a hallmark of AD pathophysiology. KCNV1 dysfunction could exacerbate this.

Synaptic Dysfunction: Through effects on synaptic transmission, KCNV1 may influence synapse loss in AD.

[Tau](/proteins/tau) Pathology: Some studies suggest potassium channel dysfunction may precede or accompany tau pathology.

Parkinson's Disease

Potential connections to PD include:

Dopaminergic Neuron Vulnerability: The selective vulnerability of substantia nigra pars compacta dopaminergic [neurons](/entities/neurons) may involve potassium channel dysfunction.

Oxidative Stress: KCNV1 function may be affected by oxidative stress, a key player in PD pathogenesis.

Mitochondrial Dysfunction: Energy metabolism alterations could impact KCNV1 trafficking and function.

Amyotrophic Lateral Sclerosis (ALS)

In motor neuron disease:

Motor Neuron Excitability: Altered excitability is observed in ALS. KCNV1 could contribute to this phenotype.

Axonal Transport: Potassium channel proper trafficking may be affected in ALS.

Other Neurodegenerative Conditions

Potential roles in:

Epilepsy: Often co-occurs with neurodegenerative conditions; KCNV1 variants may influence seizure susceptibility.

Frontotemporal Dementia: Network dysfunction in FTD may involve potassium channel alterations.

Therapeutic Implications

Drug Targets

KCNV1 and related potassium channels represent potential therapeutic targets:

Channel Activators: Compounds enhancing KCNV1 function could reduce neuronal hyperexcitability.

Modulators: Selective modulators may help restore normal excitability in disease states.

Gene Therapy: Viral vector-mediated KCNV1 expression could be explored for certain conditions.

Challenges

Several challenges exist:

Specificity: Achieving drug specificity for KCNV1 versus other Kv channel subunits is difficult.

[Blood-Brain Barrier](/entities/blood-brain-barrier): CNS penetration is required for neurological applications.

Complex Regulation: Multiple layers of regulation make targeting challenging.

Genetic Variants

Polymorphisms

Common genetic variants in KCNV1 have been studied:

Single Nucleotide Polymorphisms (SNPs): Various SNPs have been identified; some may influence channel function or expression.

Expression Quantitative Trait Loci (eQTLs): Genetic variants affecting KCNV1 expression have been documented in brain tissue.

Disease-Associated Variants

While no strongly disease-causing mutations have been firmly established:

Association Studies: Some GWAS suggest possible links to neurological phenotypes.

Rare Variants: Further research is needed on rare variants.

Research Methods

Key approaches to studying KCNV1:

Electrophysiology: Patch-clamp recordings to characterize channel properties.

Molecular Biology: Gene expression analysis, Western blotting, and immunocytochemistry.

Live Imaging: Calcium imaging to assess excitability changes.

Animal Models: Knockout and transgenic mice to study in vivo function.

Key Publications

[NCBI Gene Database - KCNV1](https://www.ncbi.nlm.nih.gov/gene/27040)

[UniProt - KCNV1 (Q9NWV8)](https://www.uniprot.org/uniprot/Q9NWV8)

[Kv channel beta subunits: diverse regulatory mechanisms (PubMed)](https://pubmed.ncbi.nlm.nih.gov/)

Animal Models and Experimental Studies

Mouse Models

Several mouse models have been used to study Kv channel function:

Kvbeta1 Knockout Mice: Mice lacking Kv channel beta subunits show altered neuronal excitability.

Conditional Knockouts: Tissue-specific deletions allow study of KCNV1 function in specific cell types.

Transgenic Overexpression: Models with elevated KCNV1 expression demonstrate trafficking effects.

Electrophysiological Studies

Key findings from experimental studies:

Heterologous Expression: KCNV1 co-expression with Kv1.x subunits enhances current density.

Biophysical Properties: Modified gating kinetics observed in recombinant systems.

Trafficking Mechanisms: Molecular mechanisms of beta subunit-mediated enhancement identified.

Phenotypic Observations

Animal model studies reveal:

Motor Behavior: Some alterations in motor coordination and gait.

Cognitive Function: Mixed results on learning and memory tasks.

Seizure Susceptibility: Altered thresholds in some models.

Clinical Significance

Diagnostic Relevance

KCNV1 may have diagnostic value:

Biomarker Potential: Expression changes in certain neurological conditions.

Genetic Testing: Rare variants may be of clinical significance.

Neuroimaging: Correlations with structural brain changes.

Patient Studies

Human research is limited:

Post-mortem Studies: Altered expression in some neurodegenerative conditions.

Genetic Studies: Ongoing efforts to identify disease-causing variants.

Clinical Trials: Not directly targeted in current clinical trials.

Comparative Biology and Evolution

Evolutionary Conservation

KCNV1 shows interesting evolutionary patterns:

Vertebrate Conservation: Present in most vertebrate species with high conservation.

Gene Duplications: Part of a larger family of Kv channel modulators.

Species Differences: Variations in expression patterns across species.

Orthologs

Key ortholog information:

Mouse Kcnv1: Highly conserved, used in experimental studies.

Zebrafish: Expresses orthologs in neuronal tissue.

Drosophila: Related genes in invertebrate model systems.

Future Directions

Research Gaps

Key questions remain:

Specific Neuronal Functions: Precise role in different neuronal subtypes.

Disease Mechanisms: Direct involvement in neurodegeneration unclear.

Therapeutic Targeting: Feasibility of targeting for CNS disorders.

Emerging Approaches

New research directions include:

Structural Studies: Cryo-EM structures of Kv channel complexes.

Single-cell Analysis: Understanding cell-type specific functions.

Gene Therapy: Viral vectors for targeted delivery.

External Links

[NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/27040)
[OMIM](https://www.omim.org/entry/609138)
[UniProt](https://www.uniprot.org/uniprot/Q9NWV8)
[Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167614)
[GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNV1)

References

Unknown, NCBI Gene Database - KCNV1 (n.d.)

Unknown, UniProt Knowledgebase - KCNV1 (n.d.)

Unknown, Ensembl Genome Browser - KCNV1 (n.d.)

[Unknown, Voltage-gated potassium channels: structure, function, and dysfunction in disease (2020)](https://doi.org/10.1016/j.tins.2020.10.001)

📖 View canonical wiki page →

Related Entities

KCNV1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-kcnv1
kg_node_id	KCNV1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-7b1e31f93234
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-kcnv1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

6

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

KCNV1 Gene

KCNV1 Gene — Potassium Voltage-Gated Channel Modifier Subfamily V Member 1

Overview

Introduction

KCNV1 Gene — Potassium Voltage-Gated Channel Modifier Subfamily V Member 1

Overview

Introduction

Protein Structure and Function

Structural Features

Channel Modulation

Expression Pattern

Role in Neuronal Physiology

Membrane Excitability

Synaptic Transmission

Axonal Conduction

Implications for Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Other Neurodegenerative Conditions

Therapeutic Implications

Drug Targets

Challenges

Genetic Variants

Polymorphisms

Disease-Associated Variants

Research Methods

Key Publications

Animal Models and Experimental Studies

Mouse Models

Electrophysiological Studies

Phenotypic Observations

Clinical Significance

Diagnostic Relevance

Patient Studies

Comparative Biology and Evolution

Evolutionary Conservation

Orthologs

Future Directions

Research Gaps

Emerging Approaches

See Also

External Links

References

💬 Discussion